StockMacro
Menu

LifeStance Health

$13.82 +83% in 6 monthsMarket cap $5.3B

LFST on XNAS, Health Care, LifeStance Health Group, Inc., job postings

Measures activity, not value. Not investment advice.

Insiders sold $758.8M in 90 days with no purchases while shares rose 124% over 12 months.

  • GoodLatest quarter revenue up 25% to $456M and twelve-month revenue up 23%
  • GoodInstitutional holders rose 15% to 324 in the latest quarter

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.

Industry
Services-health services (Health Care)
Employees
8,863
Website
lifestance.com
Listed
Nasdaq, US
Last results
4 Nov 2026
Next results
expected around 23 Feb 2027 (an estimate: a year ago it reported on 24 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $455.9M, net income $22.4M.
Quarter to 31 Dec 2021: revenue $190.0M, net income -$108.0MQuarter to 31 Dec 2021: revenue $190.0M, net income -$108.0MQuarter to 31 Mar 2022: revenue $203.1M, net income -$62.3MQuarter to 31 Mar 2022: revenue $203.1M, net income -$62.3MQuarter to 30 Jun 2022: revenue $209.5M, net income -$68.7MQuarter to 30 Jun 2022: revenue $209.5M, net income -$68.7MQuarter to 30 Sep 2022: revenue $217.6M, net income -$37.9MQuarter to 30 Sep 2022: revenue $217.6M, net income -$37.9MQuarter to 31 Dec 2022: revenue $229.4M, net income -$46.7MQuarter to 31 Dec 2022: revenue $229.4M, net income -$46.7MQuarter to 31 Mar 2023: revenue $252.6M, net income -$34.2MQuarter to 31 Mar 2023: revenue $252.6M, net income -$34.2MQuarter to 30 Jun 2023: revenue $259.6M, net income -$45.5MQuarter to 30 Jun 2023: revenue $259.6M, net income -$45.5MQuarter to 30 Sep 2023: revenue $262.9M, net income -$61.6MQuarter to 30 Sep 2023: revenue $262.9M, net income -$61.6MQuarter to 31 Dec 2023: revenue $280.6M, net income -$45.0MQuarter to 31 Dec 2023: revenue $280.6M, net income -$45.0MQuarter to 31 Mar 2024: revenue $300.4M, net income -$21.1MQuarter to 31 Mar 2024: revenue $300.4M, net income -$21.1MQuarter to 30 Jun 2024: revenue $312.3M, net income -$23.3MQuarter to 30 Jun 2024: revenue $312.3M, net income -$23.3MQuarter to 30 Sep 2024: revenue $312.7M, net income -$6.0MQuarter to 30 Sep 2024: revenue $312.7M, net income -$6.0MQuarter to 31 Dec 2024: revenue $325.5M, net income -$7.1MQuarter to 31 Dec 2024: revenue $325.5M, net income -$7.1MQuarter to 31 Mar 2025: revenue $333.0M, net income $709KQuarter to 31 Mar 2025: revenue $333.0M, net income $709KQuarter to 30 Jun 2025: revenue $345.3M, net income -$3.8MQuarter to 30 Jun 2025: revenue $345.3M, net income -$3.8MQuarter to 30 Sep 2025: revenue $363.8M, net income $1.1MQuarter to 30 Sep 2025: revenue $363.8M, net income $1.1MQuarter to 31 Dec 2025: revenue $382.2M, net income $11.7MQuarter to 31 Dec 2025: revenue $382.2M, net income $11.7MQuarter to 31 Mar 2026: revenue $403.5M, net income $14.2MQuarter to 31 Mar 2026: revenue $403.5M, net income $14.2MQuarter to 30 Jun 2026: revenue $435.4M, net income $23.6MQuarter to 30 Jun 2026: revenue $435.4M, net income $23.6MQuarter to 30 Sep 2026: revenue $455.9M, net income $22.4MQuarter to 30 Sep 2026: revenue $455.9M, net income $22.4M
31 Dec 2021RevenueNet incomeNet losstallest bar $455.9M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$455.9M$22.4M
30 Jun 2026$435.4M$23.6M
31 Mar 2026$403.5M$14.2M
31 Dec 2025$382.2M$11.7M
30 Sep 2025$363.8M$1.1M
30 Jun 2025$345.3M-$3.8M
31 Mar 2025$333.0M$709K
31 Dec 2024$325.5M-$7.1M
30 Sep 2024$312.7M-$6.0M
30 Jun 2024$312.3M-$23.3M
31 Mar 2024$300.4M-$21.1M
31 Dec 2023$280.6M-$45.0M
30 Sep 2023$262.9M-$61.6M
30 Jun 2023$259.6M-$45.5M
31 Mar 2023$252.6M-$34.2M
31 Dec 2022$229.4M-$46.7M
30 Sep 2022$217.6M-$37.9M
30 Jun 2022$209.5M-$68.7M
31 Mar 2022$203.1M-$62.3M
31 Dec 2021$190.0M-$108.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.7B $1.4B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +23% +15%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $71.9M -$9.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 48.0%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 6.2% 0.5% 1.7%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 4.3% -0.7% 1.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 4.8% 4.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $179.3M $119.4M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $218.8M $203.9M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $271.9M $284.6M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $53.1M $80.7M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.18 0.52
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $3.93
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 73.1 62.8
P/SPrice to sales: market cap divided by revenue of the last 12 months. 3.1 1.7
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 3.2 1.6
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.5 3.3

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
LifeStance HealthLFST (this company) $5.3B73.13.1+23%4.3%
Privia HealthPRVA $3.2B92.11.3+19%1.4%
US Physical TherapyUSPH $1.4B47.51.7+10%3.6%
GeneDxWGS $1.4Bloss3.0+15%-24.1%
InnovAgeINNV $1.2B1391.2+15%0.9%
PennantPNTG $1.2B33.91.0+39%3.1%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$758.8M

bought $0, sold $758.8M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+15%

324 13F filers vs 282

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

384.3M shares held by 13F filers (30 Sep 2026) of 380.2M outstanding (28 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.6%

13.7M shares sold short (30 Oct 2026) of 380.2M outstanding (28 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.4

13.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-0.8%

13.8M shares sold short in the report before, 13.7M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

56%

56% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 50%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

132

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+25%

$455.9M vs $363.8M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+42%

$14.7M vs $10.3M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

19

19 articles in the last 7 days; its usual week has 3.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.4×

19 articles in the last 7 days; its usual week has 3.5.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 16.3M, 2.1× a year earlier
  • New institutional positions 77, 1.7× a year earlier

Price $13.82 on 20 Nov 2026, +124% over 12 months (12-month range $6.18 to $14.60)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $1.4B in the last 12 months (the 12 months before: -$104.5M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 2 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $455.9M in the latest quarter, +25% on a year earlier.
Capital spending per quarter. Capital spending $14.7M in the latest quarter, +42% on a year earlier.
Institutional holders (13F filers). 324 13F filers reported holding it in the latest 13F quarter, +64% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeMany funds opening a new position: many funds opening a new position, 77 vs usual 38 (2026-09-30); 1.7x the same period a year earlier
16 Oct 20268-K and other filingsDirector or officer change
16 Oct 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Oct 2026Sharp changeShort interest spike: short interest spike, 15.5M vs usual 8.0M (2026-09-30); 2.1x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 16.3M vs usual 8.0M (2026-09-15); 2.1x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 13.6M vs usual 7.9M (2026-08-31); 1.9x the same period a year earlier
1 Sep 2026Sharp changeShort interest spike: short interest spike, 11.4M vs usual 7.9M (2026-08-14); 1.5x the same period a year earlier
7 Jul 20268-K and other filingsDirector or officer change
7 Jul 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Mar 20268-K and other filingsDirector or officer change
25 Feb 20268-K and other filingsDirector or officer change
25 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Aug 20258-K and other filingsDirector or officer change
22 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 May 20258-K and other filingsDirector or officer change
27 Feb 20258-K and other filingsDirector or officer change
27 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Dec 20248-K and other filingsA major agreement ended
3 Jul 20248-K and other filingsDirector or officer change
8 May 20248-K and other filingsDirector or officer change
12 Mar 2024Sharp changeShort interest spike: short interest spike, 27.2M vs usual 10.3M (2024-02-29); 3.0x the same period a year earlier
12 Mar 20248-K and other filingsDirector or officer change
12 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Mar 2024Sharp changeShort interest spike: short interest spike, 26.5M vs usual 9.7M (2024-02-15); 2.9x the same period a year earlier
13 Feb 2024Sharp changeShort interest spike: short interest spike, 25.9M vs usual 9.4M (2024-01-31); 2.8x the same period a year earlier
30 Jan 2024Sharp changeShort interest spike: short interest spike, 22.7M vs usual 9.3M (2024-01-12); 2.6x the same period a year earlier
16 Jan 2024Sharp changeShort interest spike: short interest spike, 19.7M vs usual 9.3M (2023-12-29); 2.1x the same period a year earlier
2 Jan 2024Sharp changeShort interest spike: short interest spike, 18.2M vs usual 9.3M (2023-12-15); 1.9x the same period a year earlier
28 Nov 2023Sharp changeShort interest spike: short interest spike, 13.6M vs usual 9.1M (2023-11-15); 1.4x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 14.0M vs usual 9.1M (2023-10-31); 1.4x the same period a year earlier
3 Nov 20228-K and other filingsDirector or officer change
8 Sep 20228-K and other filingsDirector or officer change
8 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 May 20228-K and other filingsDirector or officer change
23 May 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Mar 2022: -$146K published
Month from 1 Apr 2022: -$494K published
Month from 1 Jun 2022: -$3.9M published
Month from 1 Aug 2022: -$864K published
Month from 1 Sep 2022: -$707K published
Month from 1 Oct 2022: -$1.0M published
Month from 1 Nov 2022: -$222K published
Month from 1 Mar 2023: -$1.0M published
Month from 1 Apr 2023: -$1.6M published
Month from 1 Jun 2023: -$3.1M published
Month from 1 Jul 2023: -$3.0M published
Month from 1 Aug 2023: -$43K published
Month from 1 Sep 2023: -$413K published
Month from 1 Oct 2023: -$749K published
Month from 1 Nov 2023: -$694K published
Month from 1 Dec 2023: -$741K published
Month from 1 Mar 2024: -$4.7M published
Month from 1 Apr 2024: -$278K published
Month from 1 May 2024: -$140.6M published
Month from 1 Jun 2024: -$2.0M published
Month from 1 Aug 2024: -$33K published
Month from 1 Nov 2024: -$79K published
Month from 1 Dec 2024: -$566K published
Month from 1 Mar 2025: -$394K published
Month from 1 Apr 2025: -$34K published
Month from 1 Jun 2025: -$144K published
Month from 1 Aug 2025: -$103.0M published
Month from 1 Nov 2025: -$368K published
Month from 1 Dec 2025: -$1.9M published
Month from 1 Mar 2026: -$175.2M published
Month from 1 Apr 2026: -$528K published
Month from 1 May 2026: -$281.3M published
Month from 1 Jul 2026: -$9.1M published
Month from 1 Aug 2026: -$152.0M published
Month from 1 Sep 2026: -$226.8M published
Month from 1 Nov 2026: -$532.0M published
H-1B/E-3 applications certified
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Apr 2023: 3 published
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Apr 2026: 1 published
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2020: $118.1M; public on 18 Mar 2022
Quarter ended 31 Mar 2021: $143.1M; public on 12 May 2022
Quarter ended 31 Dec 2021: $190.0M, +61% on a year earlier; public on 18 Mar 2022
Quarter ended 31 Mar 2022: $203.1M, +42% on a year earlier; public on 12 May 2022
Quarter ended 30 Jun 2022: $209.5M, +31% on a year earlier; public on 11 Aug 2022
Quarter ended 30 Sep 2022: $217.6M, +25% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $229.4M, +21% on a year earlier; public on 10 Mar 2023
Quarter ended 31 Mar 2023: $252.6M, +24% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $259.6M, +24% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $262.9M, +21% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $280.6M, +22% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $300.4M, +19% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $312.3M, +20% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $312.7M, +19% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $325.5M, +16% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $333.0M, +11% on a year earlier; public on 8 May 2025
Quarter ended 30 Jun 2025: $345.3M, +11% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $363.8M, +16% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $382.2M, +17% on a year earlier; public on 26 Feb 2026
Quarter ended 31 Mar 2026: $403.5M, +21% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $435.4M, +26% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $455.9M, +25% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2020: $10.6M; public on 18 Mar 2022
Quarter ended 31 Mar 2021: $11.1M; public on 12 May 2022
Quarter ended 31 Dec 2021: $38.7M, +265% on a year earlier; public on 18 Mar 2022
Quarter ended 31 Mar 2022: $27.9M, +152% on a year earlier; public on 12 May 2022
Quarter ended 30 Jun 2022: $25.9M, +25% on a year earlier; public on 11 Aug 2022
Quarter ended 30 Sep 2022: $15.1M, -37% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $10.4M, -73% on a year earlier; public on 10 Mar 2023
Quarter ended 31 Mar 2023: $7.7M, -72% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $11.6M, -55% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $9.8M, -35% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $11.4M, +9.9% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $5.1M, -34% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $5.1M, -56% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $5.1M, -48% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $6.3M, -45% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $7.2M, +40% on a year earlier; public on 8 May 2025
Quarter ended 30 Jun 2025: $7.8M, +52% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $10.3M, +104% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $10.9M, +73% on a year earlier; public on 26 Feb 2026
Quarter ended 31 Mar 2026: $10.8M, +50% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $12.0M, +55% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $14.7M, +42% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 59; public on 14 Feb 2022
31 Mar 2022 report: 68; public on 16 May 2022
30 Jun 2022 report: 79; public on 15 Aug 2022
30 Sep 2022 report: 73; public on 14 Nov 2022
31 Dec 2022 report: 80; public on 14 Feb 2023
31 Mar 2023 report: 85; public on 15 May 2023
30 Jun 2023 report: 104; public on 14 Aug 2023
30 Sep 2023 report: 114; public on 14 Nov 2023
31 Dec 2023 report: 112; public on 14 Feb 2024
31 Mar 2024 report: 119; public on 15 May 2024
30 Jun 2024 report: 125; public on 14 Aug 2024
30 Sep 2024 report: 125; public on 14 Nov 2024
31 Dec 2024 report: 151; public on 14 Feb 2025
31 Mar 2025 report: 174; public on 15 May 2025
30 Jun 2025 report: 189; public on 14 Aug 2025
30 Sep 2025 report: 197; public on 14 Nov 2025
31 Dec 2025 report: 200; public on 17 Feb 2026
31 Mar 2026 report: 223; public on 15 May 2026
30 Jun 2026 report: 282; public on 14 Aug 2026
30 Sep 2026 report: 324; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it had 16.3M shares sold short in the 15 Sep 2026 report, 2.1× the same report last year; it also had 13.6M shares sold short in the 31 Aug 2026 report, 1.9× the same report last year. 5 sharp changes in all.
  • Short interest spike: had 16.3M shares sold short in the 15 Sep 2026 report, 2.1× the same report last year Public on 25 Sep 2026.
  • Insider net buying (open market): Insiders sold a net $1.4B in the last 12 months (the 12 months before: -$104.5M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 2 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 8 sales, $758.8M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
18 Nov 2026Kenneth A BurdickDirectorSell124,228$14.31$1.8MForm 4
16 Nov 2026Kenneth A BurdickDirectorSellafter exercising options159,624$14.31$2.3MForm 4
16 Nov 2026TPG GP A, LLC and 2 others10% ownerSell37,233,110$13.02$484.8MForm 4
13 Nov 2026Ryan PardoSee RemarksSellplanned in advance (10b5-1)2,804,505$14.58$40.9MForm 4
12 Nov 2026Lisa K MillerChief Operating OfficerSellplanned in advance (10b5-1)14,663$14.68$215KForm 4
12 Nov 2026Kenneth A BurdickDirectorSellafter exercising options141,589$14.51$2.1MForm 4
15 Sep 2026TPG GP A, LLC and 2 others10% ownerSell18,409,705$12.29$226.3MForm 4
4 Sep 2026Vukasin PaunovichChief Technology OfficerSell42,067$12.87$541KForm 4

324 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 77 opened a position, 37 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
TPG GP A, LLC79.7M21.0%$958.7M-32.1M-29%
FMR LLC (Fidelity)59.5M15.6%$715.3M+1.2M+2.1%
BlackRock, Inc.40.8M10.7%$490.3M+4.4M+12%
Vanguard Portfolio Management LLC17.5M4.59%$210.1M+3.5M+25%
Summit Partners L P16.6M4.37%$200.0M-6.7M-29%
Vanguard Capital Management LLC11.4M2.99%$136.9M+1.6M+17%
T. Rowe Price Associates Inc10.0M2.64%+7.3M+263%
Marshall Wace, LLP10.0M2.62%$119.8M+8.3M+512%
State Street Corp9.9M2.60%$118.9M+1.7M+20%
Jennison Associates LLC8.7M2.29%$104.8M-3.4M-28%

Company events

All 22 company events

In 12 months: 4 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
16 Oct 2026Director or officer change8-K
7 Jul 2026Director or officer change8-K
11 Mar 2026Director or officer change8-K
24 Feb 2026Director or officer change8-K
22 Aug 2025Director or officer change8-K
14 May 2025Director or officer change8-K
27 Feb 2025Director or officer change8-K
19 Dec 2024Signed a major agreement; A major agreement endedSame filing: took on new debt8-K

132 open postings; careers site tracked since 21 Nov 2026. Most in Executive & administrative support 40%, Operations & administration 23%, Sales & business development 2%, Data & analytics 2%.

PostedJobLocation
21 Nov 2026or earlierPractice CoordinatorOperations & administrationMILWAUKEE-HOWELL AVE (WI)
21 Nov 2026or earlierMedical Services CoordinatorOperations & administrationBROOKFIELD-W BLUEMOUND (WI)
21 Nov 2026or earlierPractice CoordinatorOperations & administrationOAK PARK (IL)
21 Nov 2026or earlierPractice CoordinatorOperations & administrationCOLUMBIA-ATRIUM (SC)
21 Nov 2026or earlierMedical Services CoordinatorOperations & administrationNORTH CHARLESTON (SC)
21 Nov 2026or earlierMedical Services CoordinatorOperations & administrationHINSDALE (IL)
21 Nov 2026or earlierPractice CoordinatorOperations & administrationPLAINFIELD (IL)
21 Nov 2026or earlierRegistered Nurse - Spravato ClinicNOVI (MI)

The 5 newest of 175 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 16 Nov 2026Institutional holdings change

    saw 77 13F filers open a new position in the quarter ended 30 Sep 2026, 1.7× the same quarter last year.

    Same quarter last year: 45; its normal quarter is 38.

    See the evidence
    This period
    77 (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    38
    Typical spread (median absolute deviation)
    6.5
    How far from its usual level
    +4.0
    Same quarter last year
    45
    History used
    1,918 days
    2024-09-30: 202024-12-31: 302025-03-31: 412025-06-30: 362025-09-30: 452025-12-31: 322026-03-31: 402026-06-30: 832026-09-30: 77
    the quarter ended 30 Sep 20268 earlier quartersnormal: 38

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  2. 16 Oct 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 16 Oct 2026Filings record

    Director or officer change

  4. 10 Oct 2026Short interest and volume change

    had 15.5M shares sold short in the 30 Sep 2026 report, 2.1× the same report last year.

    Same report last year: 7.3M; its normal report is 8.0M.

    See the evidence
    This period
    15.5M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    8.0M
    Typical spread (median absolute deviation)
    912K
    How far from its usual level
    +5.5
    Same report last year
    7.3M
    History used
    1,933 days
    2025-09-30: 7.3M2025-10-15: 6.9M2025-10-31: 7.0M2025-11-14: 6.4M2025-11-28: 8.1M2025-12-15: 8.5M2025-12-31: 8.2M2026-01-15: 8.0M2026-01-30: 7.9M2026-02-13: 7.8M2026-02-27: 10.3M2026-03-13: 7.8M2026-03-31: 7.2M2026-04-15: 6.6M2026-04-30: 6.9M2026-05-15: 8.6M2026-05-29: 7.9M2026-06-15: 8.0M2026-06-30: 9.6M2026-07-15: 9.5M2026-07-31: 9.6M2026-08-14: 11.4M2026-08-31: 13.6M2026-09-15: 16.3M2026-09-30: 15.5M
    the 30 Sep 2026 report24 earlier reportsnormal: 8.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 25 Sep 2026Short interest and volume change

    had 16.3M shares sold short in the 15 Sep 2026 report, 2.1× the same report last year.

    Same report last year: 7.6M; its normal report is 8.0M.

    See the evidence
    This period
    16.3M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    8.0M
    Typical spread (median absolute deviation)
    693K
    How far from its usual level
    +8.1
    Same report last year
    7.6M
    History used
    1,918 days
    2025-09-15: 7.6M2025-09-30: 7.3M2025-10-15: 6.9M2025-10-31: 7.0M2025-11-14: 6.4M2025-11-28: 8.1M2025-12-15: 8.5M2025-12-31: 8.2M2026-01-15: 8.0M2026-01-30: 7.9M2026-02-13: 7.8M2026-02-27: 10.3M2026-03-13: 7.8M2026-03-31: 7.2M2026-04-15: 6.6M2026-04-30: 6.9M2026-05-15: 8.6M2026-05-29: 7.9M2026-06-15: 8.0M2026-06-30: 9.6M2026-07-15: 9.5M2026-07-31: 9.6M2026-08-14: 11.4M2026-08-31: 13.6M2026-09-15: 16.3M
    the 15 Sep 2026 report24 earlier reportsnormal: 8.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 11 Sep 2026Short interest and volume change

    had 13.6M shares sold short in the 31 Aug 2026 report, 1.9× the same report last year.

    Same report last year: 7.3M; its normal report is 7.9M.

    See the evidence
    This period
    13.6M (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    7.9M
    Typical spread (median absolute deviation)
    620K
    How far from its usual level
    +6.2
    Same report last year
    7.3M
    History used
    1,903 days
    2025-08-29: 7.3M2025-09-15: 7.6M2025-09-30: 7.3M2025-10-15: 6.9M2025-10-31: 7.0M2025-11-14: 6.4M2025-11-28: 8.1M2025-12-15: 8.5M2025-12-31: 8.2M2026-01-15: 8.0M2026-01-30: 7.9M2026-02-13: 7.8M2026-02-27: 10.3M2026-03-13: 7.8M2026-03-31: 7.2M2026-04-15: 6.6M2026-04-30: 6.9M2026-05-15: 8.6M2026-05-29: 7.9M2026-06-15: 8.0M2026-06-30: 9.6M2026-07-15: 9.5M2026-07-31: 9.6M2026-08-14: 11.4M2026-08-31: 13.6M
    the 31 Aug 2026 report24 earlier reportsnormal: 7.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 26 Aug 2026Short interest and volume change

    had 11.4M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year.

    Same report last year: 7.4M; its normal report is 7.9M.

    See the evidence
    This period
    11.4M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    7.9M
    Typical spread (median absolute deviation)
    586K
    How far from its usual level
    +4.1
    Same report last year
    7.4M
    History used
    1,886 days
    2025-08-15: 7.4M2025-08-29: 7.3M2025-09-15: 7.6M2025-09-30: 7.3M2025-10-15: 6.9M2025-10-31: 7.0M2025-11-14: 6.4M2025-11-28: 8.1M2025-12-15: 8.5M2025-12-31: 8.2M2026-01-15: 8.0M2026-01-30: 7.9M2026-02-13: 7.8M2026-02-27: 10.3M2026-03-13: 7.8M2026-03-31: 7.2M2026-04-15: 6.6M2026-04-30: 6.9M2026-05-15: 8.6M2026-05-29: 7.9M2026-06-15: 8.0M2026-06-30: 9.6M2026-07-15: 9.5M2026-07-31: 9.6M2026-08-14: 11.4M
    the 14 Aug 2026 report24 earlier reportsnormal: 7.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 7 Jul 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 7 Jul 2026Filings record

    Director or officer change

  10. 11 Mar 2026Filings record

    Director or officer change

  11. 25 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 25 Feb 2026Filings record

    Director or officer change (dated 24 Feb 2026)

  13. 22 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 22 Aug 2025Filings record

    Director or officer change

  15. 13 Aug 2025Insiders record

    Burdick Kenneth A (director) bought 114,181 shares of LFST ($498,294) (dated 12 Aug 2025)

  16. 14 May 2025Filings record

    Director or officer change

  17. 27 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 27 Feb 2025Filings record

    Director or officer change

  19. 19 Dec 2024Filings record

    A major agreement ended

  20. 3 Jul 2024Filings record

    Director or officer change

  21. 8 May 2024Filings record

    Director or officer change

  22. 12 Mar 2024Short interest and volume change

    had 27.2M shares sold short in the 29 Feb 2024 report, 3.0× the same report last year.

    Same report last year: 9.0M; its normal report is 10.3M.

    See the evidence
    This period
    27.2M (the 29 Feb 2024 report)
    Normal report (median of 24 earlier)
    10.3M
    Typical spread (median absolute deviation)
    2.5M
    How far from its usual level
    +4.5
    Same report last year
    9.0M
    History used
    989 days
    2023-02-28: 9.0M2023-03-15: 8.4M2023-03-31: 6.9M2023-04-14: 7.7M2023-04-28: 7.7M2023-05-15: 8.0M2023-05-31: 7.8M2023-06-15: 7.7M2023-06-30: 9.5M2023-07-14: 9.4M2023-07-31: 9.0M2023-08-15: 10.0M2023-08-31: 10.6M2023-09-15: 11.9M2023-09-29: 12.5M2023-10-13: 12.4M2023-10-31: 14.0M2023-11-15: 13.6M2023-11-30: 13.8M2023-12-15: 18.2M2023-12-29: 19.7M2024-01-12: 22.7M2024-01-31: 25.9M2024-02-15: 26.5M2024-02-29: 27.2M
    the 29 Feb 2024 report24 earlier reportsnormal: 10.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 12 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  24. 12 Mar 2024Filings record

    Director or officer change

  25. 28 Feb 2024Short interest and volume change

    had 26.5M shares sold short in the 15 Feb 2024 report, 2.9× the same report last year.

    Same report last year: 9.0M; its normal report is 9.7M.

    See the evidence
    This period
    26.5M (the 15 Feb 2024 report)
    Normal report (median of 24 earlier)
    9.7M
    Typical spread (median absolute deviation)
    2.0M
    How far from its usual level
    +5.6
    Same report last year
    9.0M
    History used
    975 days
    2023-02-15: 9.0M2023-02-28: 9.0M2023-03-15: 8.4M2023-03-31: 6.9M2023-04-14: 7.7M2023-04-28: 7.7M2023-05-15: 8.0M2023-05-31: 7.8M2023-06-15: 7.7M2023-06-30: 9.5M2023-07-14: 9.4M2023-07-31: 9.0M2023-08-15: 10.0M2023-08-31: 10.6M2023-09-15: 11.9M2023-09-29: 12.5M2023-10-13: 12.4M2023-10-31: 14.0M2023-11-15: 13.6M2023-11-30: 13.8M2023-12-15: 18.2M2023-12-29: 19.7M2024-01-12: 22.7M2024-01-31: 25.9M2024-02-15: 26.5M
    the 15 Feb 2024 report24 earlier reportsnormal: 9.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 10 Feb 2024Short interest and volume change

    had 25.9M shares sold short in the 31 Jan 2024 report, 2.8× the same report last year.

    Same report last year: 9.2M; its normal report is 9.4M.

    See the evidence
    This period
    25.9M (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    9.4M
    Typical spread (median absolute deviation)
    1.7M
    How far from its usual level
    +6.4
    Same report last year
    9.2M
    History used
    960 days
    2023-01-31: 9.2M2023-02-15: 9.0M2023-02-28: 9.0M2023-03-15: 8.4M2023-03-31: 6.9M2023-04-14: 7.7M2023-04-28: 7.7M2023-05-15: 8.0M2023-05-31: 7.8M2023-06-15: 7.7M2023-06-30: 9.5M2023-07-14: 9.4M2023-07-31: 9.0M2023-08-15: 10.0M2023-08-31: 10.6M2023-09-15: 11.9M2023-09-29: 12.5M2023-10-13: 12.4M2023-10-31: 14.0M2023-11-15: 13.6M2023-11-30: 13.8M2023-12-15: 18.2M2023-12-29: 19.7M2024-01-12: 22.7M2024-01-31: 25.9M
    the 31 Jan 2024 report24 earlier reportsnormal: 9.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 25 Jan 2024Short interest and volume change

    had 22.7M shares sold short in the 12 Jan 2024 report, 2.6× the same report last year.

    Same report last year: 8.9M; its normal report is 9.3M.

    See the evidence
    This period
    22.7M (the 12 Jan 2024 report)
    Normal report (median of 24 earlier)
    9.3M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +6.0
    Same report last year
    8.9M
    History used
    941 days
    2023-01-13: 8.9M2023-01-31: 9.2M2023-02-15: 9.0M2023-02-28: 9.0M2023-03-15: 8.4M2023-03-31: 6.9M2023-04-14: 7.7M2023-04-28: 7.7M2023-05-15: 8.0M2023-05-31: 7.8M2023-06-15: 7.7M2023-06-30: 9.5M2023-07-14: 9.4M2023-07-31: 9.0M2023-08-15: 10.0M2023-08-31: 10.6M2023-09-15: 11.9M2023-09-29: 12.5M2023-10-13: 12.4M2023-10-31: 14.0M2023-11-15: 13.6M2023-11-30: 13.8M2023-12-15: 18.2M2023-12-29: 19.7M2024-01-12: 22.7M
    the 12 Jan 2024 report24 earlier reportsnormal: 9.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 11 Jan 2024Short interest and volume change

    had 19.7M shares sold short in the 29 Dec 2023 report, 2.1× the same report last year.

    Same report last year: 9.4M; its normal report is 9.3M.

    See the evidence
    This period
    19.7M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    9.3M
    Typical spread (median absolute deviation)
    1.4M
    How far from its usual level
    +5.0
    Same report last year
    9.4M
    History used
    927 days
    2022-12-30: 9.4M2023-01-13: 8.9M2023-01-31: 9.2M2023-02-15: 9.0M2023-02-28: 9.0M2023-03-15: 8.4M2023-03-31: 6.9M2023-04-14: 7.7M2023-04-28: 7.7M2023-05-15: 8.0M2023-05-31: 7.8M2023-06-15: 7.7M2023-06-30: 9.5M2023-07-14: 9.4M2023-07-31: 9.0M2023-08-15: 10.0M2023-08-31: 10.6M2023-09-15: 11.9M2023-09-29: 12.5M2023-10-13: 12.4M2023-10-31: 14.0M2023-11-15: 13.6M2023-11-30: 13.8M2023-12-15: 18.2M2023-12-29: 19.7M
    the 29 Dec 2023 report24 earlier reportsnormal: 9.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 28 Dec 2023Short interest and volume change

    had 18.2M shares sold short in the 15 Dec 2023 report, 1.9× the same report last year.

    Same report last year: 9.4M; its normal report is 9.3M.

    See the evidence
    This period
    18.2M (the 15 Dec 2023 report)
    Normal report (median of 24 earlier)
    9.3M
    Typical spread (median absolute deviation)
    1.3M
    How far from its usual level
    +4.6
    Same report last year
    9.4M
    History used
    913 days
    2022-12-15: 9.4M2022-12-30: 9.4M2023-01-13: 8.9M2023-01-31: 9.2M2023-02-15: 9.0M2023-02-28: 9.0M2023-03-15: 8.4M2023-03-31: 6.9M2023-04-14: 7.7M2023-04-28: 7.7M2023-05-15: 8.0M2023-05-31: 7.8M2023-06-15: 7.7M2023-06-30: 9.5M2023-07-14: 9.4M2023-07-31: 9.0M2023-08-15: 10.0M2023-08-31: 10.6M2023-09-15: 11.9M2023-09-29: 12.5M2023-10-13: 12.4M2023-10-31: 14.0M2023-11-15: 13.6M2023-11-30: 13.8M2023-12-15: 18.2M
    the 15 Dec 2023 report24 earlier reportsnormal: 9.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 28 Nov 2023Short interest and volume change

    had 13.6M shares sold short in the 15 Nov 2023 report, 1.4× the same report last year.

    Same report last year: 9.7M; its normal report is 9.1M.

    See the evidence
    This period
    13.6M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    9.1M
    Typical spread (median absolute deviation)
    778K
    How far from its usual level
    +3.9
    Same report last year
    9.7M
    History used
    883 days
    2022-11-15: 9.7M2022-11-30: 9.0M2022-12-15: 9.4M2022-12-30: 9.4M2023-01-13: 8.9M2023-01-31: 9.2M2023-02-15: 9.0M2023-02-28: 9.0M2023-03-15: 8.4M2023-03-31: 6.9M2023-04-14: 7.7M2023-04-28: 7.7M2023-05-15: 8.0M2023-05-31: 7.8M2023-06-15: 7.7M2023-06-30: 9.5M2023-07-14: 9.4M2023-07-31: 9.0M2023-08-15: 10.0M2023-08-31: 10.6M2023-09-15: 11.9M2023-09-29: 12.5M2023-10-13: 12.4M2023-10-31: 14.0M2023-11-15: 13.6M
    the 15 Nov 2023 report24 earlier reportsnormal: 9.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 10 Nov 2023Short interest and volume change

    had 14.0M shares sold short in the 31 Oct 2023 report, 1.4× the same report last year.

    Same report last year: 9.8M; its normal report is 9.1M.

    See the evidence
    This period
    14.0M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    9.1M
    Typical spread (median absolute deviation)
    709K
    How far from its usual level
    +4.6
    Same report last year
    9.8M
    History used
    868 days
    2022-10-31: 9.8M2022-11-15: 9.7M2022-11-30: 9.0M2022-12-15: 9.4M2022-12-30: 9.4M2023-01-13: 8.9M2023-01-31: 9.2M2023-02-15: 9.0M2023-02-28: 9.0M2023-03-15: 8.4M2023-03-31: 6.9M2023-04-14: 7.7M2023-04-28: 7.7M2023-05-15: 8.0M2023-05-31: 7.8M2023-06-15: 7.7M2023-06-30: 9.5M2023-07-14: 9.4M2023-07-31: 9.0M2023-08-15: 10.0M2023-08-31: 10.6M2023-09-15: 11.9M2023-09-29: 12.5M2023-10-13: 12.4M2023-10-31: 14.0M
    the 31 Oct 2023 report24 earlier reportsnormal: 9.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 3 Nov 2022Filings record

    Director or officer change

  33. 8 Sep 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 8 Sep 2022Filings record

    Director or officer change

  35. 23 May 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 23 May 2022Filings record

    Director or officer change

  37. 26 Aug 2021Filings record

    Director or officer change

  38. 16 Aug 2021Institutional holdings record

    TPG Group Holdings (SBS) Advisors, Inc. opened a $4.9B position (2021Q2 13F)

  39. 15 Jun 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 15 Jun 2021Filings record

    Director or officer change

Showing the newest 40 of 43 entries; narrow the window or the kind of data to see older ones.

Not listed: 186 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001845257
Ticker
LFST
Domain
lifestance.com
Employer name
LifeStance Health Group, Inc., LifeStance Health, Inc. (2 unverified)
Fein
47-5361406 (1 unverified)
Hq location
AZ|SCOTTSDALE|85251 (1 unverified)
Name
Anxiety and Stress Management Institute, LLC, Ascendant Behavioral Health, LLC, Balance Women's Health, LLC, Behavioral Health Practice Services, LLC and 26 more
Wikipedia
Lifestance Health
  • DOL H-1B labor condition applications and PERM certifications49 data points9 Mar 2020 to 6 Jul 2026
  • SEC Form 13F institutional holdings1 record, 198 data points30 Jun 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)76 records17 May 2021 to 12 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)307 data points31 Dec 2018 to 28 Oct 2026
  • SEC Form 4 insider transactions130 records, 328 data points16 Jun 2021 to 18 Nov 2026
  • FINRA short interest (twice monthly)386 data points15 Jun 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2740 data points10 Jun 2021 to 20 Nov 2026
  • Wikipedia pageviews10 data points11 Nov 2026 to 20 Nov 2026